急性淋巴细胞性白血病(all)是一种发生于血液和骨髓的癌症——骨髓(译者：此处指红骨髓)是指作为造血场所的骨内的海绵组织。
Acute lymphocytic leukemia (ALL) is a type of cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made.
急性淋巴细胞白血病和急性粒细胞性白血病均由癌变的母细胞引起，如淋巴母细胞或原始粒细胞。
Acute lymphocytic leukemia and acute myelogenous leukemia are each composed of blast cells, known as lymphoblasts or myeloblasts.
相对于急性白血病，慢性淋巴细胞白血病和慢性粒细胞性白血病通常进展缓慢。
Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
恶性淋巴增生包括淋巴瘤、急性淋巴细胞白血病和慢性淋巴细胞白血病。
Lymphoproliferative malignancies include lymphomas and acute lymphoblastic and chronic lymphocytic leukemias.
我们进行了一项临床试验旨在分析伏立康唑在急性髓细胞白血病化疗诱导阶段预防肺部浸润的有效性和安全性。
We conducted a trial to analyze the efficacy and safety of voriconazole in the prevention of lung infiltrates during induction chemotherapy for acute myelogenous leukaemia (AML).
在高浓度，筹备工作已经表明，以抑制急性淋巴细胞白血病和急性粒细胞白血病细胞。
In high concentrations, preparations have shown to inhibit cells from acute lymphocytic and acute granulocytic leukemia.
别名有，急性淋巴母细胞性白血病和急性淋巴性白血病。
Other names for ALL are acute lymphoblastic leukemia and acute lymphoid leukemia.
在急性髓细胞性白血病aml和急性淋巴细胞性白血病all中，原始的急性白血病细胞进展、形成多达上亿个的白血病细胞。
In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL), the original acute leukemia cell goes on to form about a trillion more leukemia cells.
为此用多参数流式细胞术三色荧光直接标记法进行免疫分型，对急性白血病的确诊、治疗和预后有重要的临床意义。
In conclusion, multiparameter flow cytometry and three-color direct immunofluorescence staining methods may be of important clinical significance in diagnosis, therapy and prognosis of acute leukemia.
目的探讨急性白血病合并严重血小板增多症的细胞遗传学特点及其临床和实验室特征。
Objective To investigate the cytogenetic features as well as clinical and laboratory criteria of acute leukemia complicated with severe thrombocytosis.
目的了解多中心协作化疗方案(MCP方案)对急性淋巴细胞白血病(all)和非霍奇金淋巴瘤(NHL)患儿肾脏功能的影响。
Objective to investigate the renal damages in children with acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma (NHL) who received the intensive multicenter-protocols (MCP).
目的观察四硫化四砷（TATS）治疗初治和复发急性早幼粒细胞白血病（APL）过程中细胞形态学及细胞遗传学变化，探讨其作用机制。
Objective To study the morphologic and cytogenetic change in acute promyelocytic leukemia (APL) patients during the tetra arsenic tetra sulfide (TATS) treatment and the mechanism of TATS.
目的：通过血药浓度监测，提高对小儿急性淋巴细胞白血病大剂量甲氨蝶呤化疗的有效性和安全性。
OBJECTIVE: to improve the efficacy and safety of high dose methotrexate (HDMTX) chemotherapy in the treatment of children with acute lymphoblastic leukemia through blood concentration monitoring.
目的：探讨急性混合细胞白血病的诊断标准和治疗方案。
Objective: To investigate the diagnostic criterion and the treatment strategy of mixed acute leukemia.
目的探讨毫米波对人急性早幼粒白血病细胞增殖和凋亡的影响。
Objective To investigate the effect of millimeter wave radiation on proliferation and apoptosis of acute promyelocytic leukemia cell line NB 4 cells.
靶向过氧化物酶I/II，一种天然二帖类物质，诱导分化和根除急性早幼粒细胞白血病。
Targeting peroxiredoxin I/II by Adenanthin, a naturally occurring diterpenoid, to induce differentiation and eradicate leukemia-initiating cells of acute promyelocytic leukemia.
目的观察急性白血病患者血清LDH及HBDH的含量变化，探讨血清LDH和HBDH与白血病细胞变化的关系及其临床意义。
Objective To detect the changes of serum LDH and HBDH, and to study the relation between serum LDH, HBDH and the cells of leukemia and its clinical significance in patients with acute leukemia.
近来，研究发现急性淋巴细胞白血病(all)和慢性粒细胞白血病(CML)患者血清中il - 18水平高于正常人。
Recently, elevated IL-18 levels were found in serum from some leukemia patients, especially those with acute lymphocytic leukemia (all) and chronic myeloid leukemia (CML).
目的观察马斯平应用于急性白血病化疗后粒细胞缺乏并感染的疗效和不良反应。
Objective To observe the curative effect and side effect of maxipime(cefepime) in treating infection caused by postchemotherapeutic granulocytopenia in patients with acute leukemia.
目的报道1例以CD7+和双重t（8；21）易位为特征的近四倍体克隆急性髓细胞性白血病（AML）。
Objective To report a case of acute myeloid leukemia (AML) with CD7 + near-tetraploid clones by doublet(8; 21).
目的：探讨急性淋巴细胞白血病(all)与急性非淋巴细胞白血病(ANLL)AT M基因和BRCA2基因杂合性缺失及其相互关系。
Objective: To investigate the loss of heterozygosity (LOH) of ATM gene and BRCA2 gene and explore the relationship between two genes in patients with ALL and ANLL.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞性白血病”和“慢性髓细胞性白血病”通常进程相对缓慢。
"Chronic" leukemias have few or no blast cells. "chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
研究方法：用流式细胞仪检测30例急性髓性白血病的P_(170)和活化t细胞的表达。
Methods: Flow cytometer (FCM) was used in detection of the expression of P170 and active t cell in leukemic cells from 30 cases of AML patients.
丙卡巴肼、氮芥和异环磷酰胺：可增加患骨髓增生异常综合症和急性粒细胞白血病的风险。
Procarbazine, nitrogen mustard, and ifosfamide, which can increase risk for myelodysplastic syndromes and acute myelogenous leukemia.
目的分析急性混合细胞白血病(HAL)的临床和实验室特征以及疗效和预后。
Objective to analyze the clinical and laboratorial features of hybrid acute leukemia (HAL), as well as the effect of chemotherapy and the prognosis of HAL.
目的探讨急性白血病患儿外周血白血病细胞转铁蛋白受体表达与细胞增殖力和铁代谢的关系。
Objective To explore the relationship between transferrin receptor (TfR) expression and cell proliferation capacity and iron metabolism status.
急性淋巴细胞白血病(all)患者即使病情已有所缓解，仍需要接受进一步治疗，称之为巩固治疗和维持治疗。
More treatment is needed even after a patient with all is in remission. This is called consolidation therapy and maintenance therapy.
急性淋巴细胞白血病(all)患者即使病情已有所缓解，仍需要接受进一步治疗，称之为巩固治疗和维持治疗。
More treatment is needed even after a patient with all is in remission. This is called consolidation therapy and maintenance therapy.
应用推荐